The Effect of Using Virtual Reality Glasses on Anxiety-related Radial Vasospasm in Patients Undergoing Transradial Coronary Angiography
Launched by MERSIN UNIVERSITY · Dec 8, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is examining whether using virtual reality (VR) glasses can help reduce anxiety-related issues during a specific heart procedure called transradial coronary angiography. This procedure involves accessing the heart through the wrist instead of the groin, which is generally safer and allows for quicker recovery. However, some patients experience a problem called radial artery spasm, which can make the procedure more difficult or even lead to complications. Many patients also feel anxious during such procedures, and this trial aims to see if VR can help manage that anxiety and improve the success of the procedure.
To participate in the study, individuals must be 18 years or older and scheduled for a transradial coronary angiography for reasons other than a heart attack. They should not have any history of anxiety disorders, psychiatric issues, or certain other health problems. Participants will be asked to use VR glasses during their procedure, and the study will assess whether this technology helps reduce anxiety and improve outcomes. It's important to note that participants will need to understand Turkish and agree to join the study by signing an informed consent form.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Indicated for coronary angiography via the transradial approach for reasons other than Acute Coronary Syndrome.
- • Patients with no prior history of coronary angiography
- • Patients aged 18 years and older
- • Patients who are conscious, oriented, cooperative, and able to read and understand Turkish.
- • Patients without any physical issues that would prevent the use of virtual reality glasses.
- • Patients with no known malignancy, neuropsychiatric disorders, or diagnosed anxiety disorders.
- • Patients who agree to participate in the study and sign the "Informed Consent Form" will be included.
- Exclusion Criteria:
- • Patients indicated for coronary angiography due to Acute Coronary Syndrome,
- • Patients undergoing coronary angiography via an approach other than the transradial route,
- • Patients under the age of 18,
- • Patients who are unconscious, disoriented, or uncooperative,
- • Patients who cannot read or understand Turkish,
- • Patients with physical issues preventing the use of virtual reality glasses,
- • Patients with known neuropsychiatric disorders, diagnosed anxiety disorders, or those receiving antidepressant or anxiolytic treatment,
- • Patients with malignancy,
- • Patients who do not agree to participate or who do not sign the "Informed Consent Form" will be excluded.
About Mersin University
Mersin University is a distinguished academic institution located in Mersin, Turkey, committed to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to facilitate groundbreaking studies. Mersin University aims to contribute to the global medical community by fostering the development of new therapies and improving patient outcomes through rigorous scientific inquiry and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mersin, Yenisehir, Turkey
Patients applied
Trial Officials
ahmet b KECECI, Research Assistant
Principal Investigator
Mersin University faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported